GSK3β-driven SOX2 overexpression is a targetable vulnerability in esophageal squamous cell carcinoma

Oncogene, Published online: 22 June 2023; doi:10.1038/s41388-023-02748-wGSK3β-driven SOX2 overexpression is a targetable vulnerability in esophageal squamous cell carcinoma
Source: Oncogene - Category: Cancer & Oncology Authors: Source Type: research